Upregulation of nuclear factor-related kappa b suggests a disorder of transcriptional regulation in minimal change nephrotic syndrome

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Audard, Vincent ^a,b,c   Pawlak, André ^a,b   Candelier, Marina ^a,b   Lang, Philippe ^a,b,c   Sahali, Djillali ^a,b,c  

^a INSERM U955   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; I KAPPA B; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; DNA BINDING PROTEIN; NFRKB PROTEIN, HUMAN;

ADULT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PROTEIN BINDING; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; RELAPSE; REMISSION; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSCRIPTION REGULATION; UPREGULATION; ADOLESCENT; CELL STRAIN HEK293; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETICS; ISOLATION AND PURIFICATION; LEUKEMIA CELL LINE; LIPOID NEPHROSIS; METABOLISM; MIDDLE AGED; MOLECULAR CLONING; PATHOLOGY; PHYSIOLOGY; RECURRENT DISEASE;

ADOLESCENT; ADULT; CLONING, MOLECULAR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HEK293 CELLS; HUMANS; JURKAT CELLS; MIDDLE AGED; NEPHROSIS, LIPOID; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECURRENCE; TRANSCRIPTION, GENETIC; UP-REGULATION; YOUNG ADULT;

EID: 84856088656     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030523     Document Type: Article

References (32)

1. Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, et al. (2002) Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis 39: 503-512.
2. Eddy AA, Symons JM, (2003) Nephrotic syndrome in childhood. Lancet 362: 629-639.
3. Shalhoub RJ, (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2: 556-560.
4. Mathieson PW, (2007) Minimal change nephropathy and focal segmental glomerulosclerosis. Semin Immunopathol 29: 415-426.
5. Zhang S, Audard V, Fan Q, Pawlak A, Lang P, et al. (2011) Immunopathogenesis of idiopathic nephrotic syndrome. Contrib Nephrol 169: 94-106.
6. Audard V, Larousserie F, Grimbert P, Abtahi M, Sotto JJ, et al. (2006) Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int 69: 2251-2260.
7. Orman SV, Schechter GP, Whang-Peng J, Guccion J, Chan C, et al. (1986) Nephrotic syndrome associated with a clonal T-cell leukemia of large granular lymphocytes with cytotoxic function. Arch Intern Med 146: 1827-1829.
8. Karras A, de Montpreville V, Fakhouri F, Grunfeld JP, Lesavre P, (2005) Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature. Nephrol Dial Transplant 20: 1075-1082.
9. Valanciute A, le Gouvello S, Solhonne B, Pawlak A, Grimbert P, et al. (2004) NF-kappa B p65 antagonizes IL-4 induction by c-maf in minimal change nephrotic syndrome. J Immunol 172: 688-698.
10. Berger SL, (1999) Gene activation by histone and factor acetyltransferases. Curr Opin Cell Biol 11: 336-341.
11. Murr R, (2010) Interplay between different epigenetic modifications and mechanisms. Adv Genet 70: 101-141.
12. Conaway RC, Conaway JW, (2009) The INO80 chromatin remodeling complex in transcription, replication and repair. Trends Biochem Sci 34: 71-77.
13. Yao T, Song L, Jin J, Cai Y, Takahashi H, et al. (2008) Distinct modes of regulation of the Uch37 deubiquitinating enzyme in the proteasome and in the Ino80 chromatin-remodeling complex. Mol Cell 31: 909-917.
14. Jonsson ZO, Jha S, Wohlschlegel JA, Dutta A, (2004) Rvb1p/Rvb2p recruit Arp5p and assemble a functional Ino80 chromatin remodeling complex. Mol Cell 16: 465-477.
15. Mizuguchi G, Shen X, Landry J, Wu WH, Sen S, et al. (2004) ATP-driven exchange of histone H2AZ variant catalyzed by SWR1 chromatin remodeling complex. Science 303: 343-348.
16. Affar el B, Gay F, Shi Y, Liu H, Huarte M, et al. (2006) Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression. Mol Cell Biol 26: 3565-3581.
17. Sahali D, Pawlak A, Valanciute A, Grimbert P, Lang P, et al. (2002) A novel approach to investigation of the pathogenesis of active minimal- change nephrotic syndrome using subtracted cDNA library screening. J Am Soc Nephrol 13: 1238-1247.
18. Karin M, Liu Z, Zandi E, (1997) AP-1 function and regulation. Curr Opin Cell Biol 9: 240-246.
19. Liu B, Shuai K, (2008) Regulation of the sumoylation system in gene expression. Curr Opin Cell Biol 20: 288-293.
20. Saito K, Kagawa W, Suzuki T, Suzuki H, Yokoyama S, et al. (2010) The putative nuclear localization signal of the human RAD52 protein is a potential sumoylation site. J Biochem 147: 833-842.
21. Shaulian E, Karin M, (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4: E131-136.
22. Abate C, Patel L, Rauscher FJ 3rd, Curran T, (1990) Redox regulation of fos and jun DNA-binding activity in vitro. Science 249: 1157-1161.
23. Kang SM, Beverly B, Tran AC, Brorson K, Schwartz RH, et al. (1992) Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 257: 1134-1138.
24. Rincon M, Derijard B, Chow CW, Davis RJ, Flavell RA, (1997) Reprogramming the signalling requirement for AP-1 (activator protein-1) activation during differentiation of precursor CD4+ T-cells into effector Th1 and Th2 cells. Genes Funct 1: 51-68.
25. Klemsz MJ, Justement LB, Palmer E, Cambier JC, (1989) Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands. J Immunol 143: 1032-1039.
26. Francis DA, Karras JG, Ke XY, Sen R, Rothstein TL, (1995) Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int Immunol 7: 151-161.
27. Elie V, Fakhoury M, Deschenes G, Jacqz-Aigrain E, (2011) Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives. Pediatr Nephrol.
28. Ballestar E, (2011) Epigenetic alterations in autoimmune rheumatic diseases. Nat Rev Rheumatol 7: 263-271.
29. Krukowski K, Eddy J, Kosik KL, Konley T, Janusek LW, et al. (2011) Glucocorticoid dysregulation of natural killer cell function through epigenetic modification. Brain Behav Immun 25: 239-249.
30. Smith KM, Davidson JM, Garside P, (2002) T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division. Immunology 106: 144-158.
31. Gimenez Llort A, Vila Cots J, Camacho Diaz JA, Vila Santandreu A, Concheiro Guisan A, et al. (2002) Nephrotic syndrome associated with Celiac disease. A report of five cases. Nephron 92: 950.
32. Sahali D, Pawlak A, Le Gouvello S, Lang P, Valanciute A, et al. (2001) Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. J Am Soc Nephrol 12: 1648-1658.